Browse by Author "Majem, M."

Now showing items 1-6 of 6

A Spanish Initiative to Know the Unmet Needs of Women with Lung Cancer:

2019- Campelo, R. G.; Vázquez Rivera, Francisca; Firvida Perez, Jose Luis; Lazaro Quintela, Martín; Vazquez, S.; [et al.]
Agreement Between Different Methodologies for Non-Invasive p.T790M and EGFR Sensitizing Mutation Testing

2019- Romero, A.; Jantus, E.; Molina-Vila, M. A.; Insa, A.; Cruz, P.; [et al.]
Alectinib after failure to crizotinib in patients with ALK-positive non-small cell lung cancer: results from the Spanish early access program

2022- Bernabé-Caro, R.; Garrido, P.; García Campelo, María del Rosario; Palmero, R.; Artal, Á.; [et al.]
Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology

2019- Gravalos, C.; Sanmartin, O.; Gurpide, A.; Espana, A.; Majem, M.; [et al.]
PD-1/PD-L1 Inhibitors as Monotherapy in the First-Line Treatment of Advanced Non-Small Cell Lung Cancer Patients with High PD-L1 Expression: An Expert Position Statement

2023- Isla, D.; Sánchez, A.; Casal Rubio, Joaquín; Cobo, M.; Majem, M.; [et al.]
Tumor microenvironment gene expression profiles associated to complete pathological response and disease progression in resectable NSCLC patients treated with neoadjuvant chemoimmunotherapy

2022- Casarrubios, M.; Provencio, M.; Nadal, E.; Insa, A.; García Campelo, María del Rosario; [et al.]